METTL3 and neoplasm: More strikingly, the combination of shMETTL3 and cisplatin exhibited the most profound tumor inhibition effect on CAL27-A, suggesting that silencing METTL3 enhanced the therapeutical effect of cisplatin on arecoline-transformed OSCC (Figure 5D,E).